Table 3 Comparison of demographics and clinical features of DF and DHF

Age > 40 years

167 (25)

137 (23.3)

30 (38)

0.005

Male gender

378 (56.7)

326 (55.4)

52 (55.8)

0.08

Urban resident

403 (60.4)

346 (41.2)

57 (72.2)

0.023

Temperature > 38 C^o

229 (34.3)

197 (33.5)

32 (40.5)

0.218

Obesity

94 (14.1)

82 (13.2)

12 (15.2)

0.467

Co-morbidities

 DM

36 (5.4)

13 (2.2)

23 (29.1)

0.001

 HTN

35 (5.2)

17 (2.9)

18 (22.4)

0.021

 CKD

33 (4.9)

26 (4.4)

7 (8.9)

0.085

 IHD

25 (3.7)

19 (3.2)

6 (7.6)

0.178

 CHF

2 (0.3)

2 (0.3)

0 (0)

-

 HPL

8 (1.2)

7 (1.2)

1 (1.3)

0.649

Risk group association^a

264 (39.6)

232 (39.5)

32 (40.5)

0.858

Secondary infection

73 (10.9)

58 (9.9)

18 (22.8)

0.015

Warning signs

271 (40.6)

224 (38.1)

47 (59.7)

0.000

Positive Hess test

101 (15.1)

85 (14.5)

16 (20.3)

0.177

Low MAP

37 (5.5)

34 (5.8)

3 (3.8)

0.469

Elevate Scr (AKI)

95 (14.2)

58 (9.9)

37 (65.8)

0.000

Thrombocytopenia

395 (59.2)

343 (58.3)

56 (70.8)

0.042

Leukopenia

363 (54.4)

321 (54.6)

42 (53.2)

0.596

Leukocytosis

36 (5.4)

32 (5.4)

4 (5.1)

0.842

Elevated ALT

362 (54.3)

315 (53.6)

47 (59.5)

0.321

Elevated AST

447 (67)

380 (64.6)

67 (84.8)

0.000

Elevated ALP

113 (19.9)

117 (19.9)

16 (20.3)

0.885

Transaminitis

360 (54)

311 (52.9)

49 (62)

0.125

Rhabdomyolosis

49 (7.3)

34 (5.8)

15 (19)

0.000

Multiple organ dysfunctions

138 (20.7)

97 (16.5)

43 (54.4)

0.000

Urinary sedimentations

96 (14.4)

78 (13.3)

18 (22.8)

0.034

Hemoconcentration

73 (10.9)

56 (9.5)

17 (21.5)

0.001

Prolonged PT and aPTT

116 (17.4)

93 (15.6)

23 (29.1)

0.003

Delayed Hospitalization (>3 days of onset of illness)

153 (22.9)

105 (17.9 %)

48 (60.8)

0.000

Death

8 (1.2)

6 (1)

2 (2.5)

0.243